bioXXmed AG (FRA:T5O) FCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:T5O bioXXmed AG FRA:T5O
38 GF Score
Price €0.81
GF Value €10.79
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is bioXXmed AG FCF Margin %?

bioXXmed AG FRA:T5O +5.19% 38 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates FRA:T5O with a GF Score™ of 38/100 and a GF Value™ of €10.79 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 950 Biotechnology companies, bioXXmed AG ranks worse than 105263.05% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. bioXXmed AG's Free Cash Flow for the six months ended in Dec. 2025 was €0.22 Mil. bioXXmed AG's Revenue for the six months ended in Dec. 2025 was €0.00 Mil. Therefore, bioXXmed AG's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, bioXXmed AG's current FCF Yield % is 0.00%.

The historical rank and industry rank for bioXXmed AG's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of bioXXmed AG was -33.33%. The lowest was -127200.00%. And the median was -4037.06%.

FRA:T5O's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -81.28
* Ranked among companies with meaningful FCF Margin % only.

bioXXmed AG FCF Margin % Related Terms

bioXXmed AG FCF Margin % Historical Data

* Premium members only.

The historical data trend for bioXXmed AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

bioXXmed AG FCF Margin % Chart

bioXXmed AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,780.00 -7,616.67 -4,294.12 -33.33 0.00

bioXXmed AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 493,740.00 0.00 16,300.00 -1,288.24 0.00

FRA:T5O vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, bioXXmed AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

bioXXmed AG FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, bioXXmed AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where bioXXmed AG's FCF Margin % falls into.


FRA:T5O
38GF Score
bioXXmed AG FRA:T5O
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

bioXXmed AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

bioXXmed AG's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=0/0.017
=0.00 %

bioXXmed AG's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0.219/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
bioXXmed AG (FRA:T5O) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on bioXXmed AG and its competitors. According to the industry distribution chart, bioXXmed AG ranks #999999 out of 950 companies in the Biotechnology industry.
Is bioXXmed AG's FCF Margin % too high?
bioXXmed AG's current FCF Margin % is 0.00%. Based on the distribution chart, bioXXmed AG ranks #999999 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, bioXXmed AG has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does bioXXmed AG's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, bioXXmed AG ranks #999999 out of 950 companies for FCF Margin %. This places bioXXmed AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on bioXXmed AG and its competitors. bioXXmed AG's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is bioXXmed AG stock overvalued right now?
Based on GuruFocus' analysis, bioXXmed AG (FRA:T5O) is currently considered Possible Value Trap. The stock's GF Value™ is €10.79, compared to a current price of €0.81 — trading 92.5% below its estimated fair value. The current FCF Margin % is 0.00%. bioXXmed AG's overall GF Score™ is 38/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For bioXXmed AG (FRA:T5O), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is bioXXmed AG (FRA:T5O) Overvalued in 2026?

Based on GuruFocus' analysis, bioXXmed AG stock appears to be undervalued. The current stock price of €0.81 is trading 92.5% below its estimated GF Value™ of €10.79. GuruFocus considers bioXXmed AG to be Possible Value Trap.

Key valuation signals for FRA:T5O:

  • FCF Margin %: 0.00%
  • GF Value™: €10.79 vs. price of €0.81 (92.5% below fair value)
  • GF Score™: 38/100 with 3 warning signs

No single metric tells the full story. See the FRA:T5O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

bioXXmed AG Business Description

Other Exchanges T5O:Germany
Address Riedstrasse 2, Darmstadt, HE, DEU, 64295
bioXXmed AG is an investment and holding company in the technology sector. It originated from CytoTools GmbH, a successful German technology enterprise from the pharmaceuticals and medical products field.
38GF Score

Get the complete analysis for FRA:T5O

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.81
Price
€10.79
GF Value